Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy | MicrobiomeTrials← Back to trialsNCT02262832
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2014-10-09Est. Completion: 2027-07-31
Enrollment target: 24 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
LipodystrophyDiabetesDiet Modification
To evaluate the therapeutic efficacy and metabolic impact of a low energy diet (LED) in people with familial partial lip…
Cambridge, United KingdomCompleted Mar 1, 2026
Nephrotic SyndromeLipodystrophyMetabolic SyndromeHealthy VolunteerDiabetesMetabolic Associated Steatotic Liver Disease
Background:
Abnormal fats in the blood can lead to many problems, including heart disease. Researchers want to learn mo…
Bethesda, United States
Est. completion Feb 1, 2030